-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FoCnlmclz0dUKLLIp1vfs27JoIFMvWF8uDoMFABSb6Jz0P9s4XDiIG+XXvNGUbv1 DEbbjRIgN5xq2ZV3uVuVJw== 0000910680-03-000192.txt : 20030214 0000910680-03-000192.hdr.sgml : 20030214 20030214155934 ACCESSION NUMBER: 0000910680-03-000192 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030214 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MURPHY JAMES R CENTRAL INDEX KEY: 0001218893 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 65 LAFAYETTE RD STREET 2: THIRD FL CITY: NORTH HAMPTON STATE: NH ZIP: 03862 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BENTLEY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821616 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 591513162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-40113 FILM NUMBER: 03567839 BUSINESS ADDRESS: STREET 1: 65 LAFAYETTE RD 3RD FLR CITY: NORTH HAMPTON STATE: NH ZIP: 03862 BUSINESS PHONE: 6039648006 MAIL ADDRESS: STREET 1: 65 LAFAYETTE RD 3RD FLR CITY: NORTH HAMPTON STATE: NH ZIP: 03862 FORMER COMPANY: FORMER CONFORMED NAME: BELMAC CORP /FL/ DATE OF NAME CHANGE: 19920703 SC 13G 1 sc13gjmurphy022003.txt J.R. MURPHY - 12/31/2002 ----------------------------- OMB APPROVAL ----------------------------- OMB Number 3235-0145 Expires: December 31, 2005 Estimated average burden hours per response ..... 11 ----------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 Bentley Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $.02 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 082657 10 7 ------------------------------------------------------------------------------ (CUSIP Number) December 31, 2002 ----------------------------------------------------------- (Date of Event which requires filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Statement is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 Pages CUSIP No. 082657 10 7 13G Page 2 of 5 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON James R. Murphy - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 977,363 SHARES ------------------------------------------------------------- BENEFICIALLY OWNED BY 6 SHARED VOTING POWER EACH 0 REPORTING ------------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH 977,363 ------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 977,363 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [X] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.3% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT CUSIP No. 082657 10 7 13G Page 3 of 5 Pages - -------------------------------------------------------------------------------- Item 1(a) NAME OF ISSUER: Bentley Pharmaceuticals, Inc. Item 1(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 65 Lafayette Road, Third Floor North Hampton, NH 03862 Item 2(a) NAME OF PERSON FILING: James R. Murphy Item 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 65 Lafayette Road, Third Floor North Hampton, NH 03862 Item 2(c) CITIZENSHIP: United States Item 2(d) TITLE OF CLASS OF SECURITIES: Common Stock, par value $.02 Item 2(e) CUSIP NUMBER: 082657 10 7 Item 3 IF THIS STATEMENT IS FILED PURSUANT TO 240.13d-1(b) or 240.13d-2(b) or (c): Not applicable. Item 4 OWNERSHIP: (a) Amount Beneficially Owned: 977,363 shares* (b) Percent of Class: 5.3% (c) Number of shares as to which the person has: i. sole power to vote or to direct the vote: 977,363 shares* ii. shared power to vote or direct the vote: 0 CUSIP No. 082657 10 7 13G Page 4 of 5 Pages - -------------------------------------------------------------------------------- iii. sole power to dispose or to direct the disposition of: 977,363 shares* iv. shared power to dispose or to direct the disposition of: 0 * includes 100 shares owned by Reporting Person's son, as to which Reporting Person disclaims beneficial ownership; also includes 854,500 shares issuable upon the exercise of warrants and options which are exercisable within 60 days but are not currently outstanding Item 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not applicable. Item 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not applicable. Item 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not applicable. Item 8 IDENTIFICATION AND CLASSIFICATION OF MEMBER OF THE GROUP: Not applicable. Item 9 NOTICE OF DISSOLUTION OF GROUP: Not applicable. Item 10 CERTIFICATION: Not applicable. CUSIP No. 082657 10 7 13G Page 5 of 5 Pages - -------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 14, 2003 ---------------------------------- Date /S/ JAMES R. MURPHY ---------------------------------- Signature James R. Murphy ---------------------------------- Name/Title -----END PRIVACY-ENHANCED MESSAGE-----